Navigation Links
Jarrow Formulas Launches New Products Featuring BioCell Collagen II(R)
Date:10/4/2007

The two new products, Skin Optimizer and Hyaluronic Acid Complex, promote

skin and joint health benefits.

ANAHEIM, Calif., Oct. 4 /PRNewswire/ -- Jarrow Formulas, recognized in July by Nutrition Business Journal, selected BioCell Collagen II -- a patented and clinically supported natural ingredient to enhance the effectiveness of two new Jarrow Formulas products -- Skin Optimizer and Hyaluronic Acid Complex. The new formulations featuring BioCell Collagen II supply a naturally occurring matrix of bioavailable hydrolyzed collagen type II, hyaluronic acid (HA) and chondroitin sulfate (CS), and is made in the United States under strict quality control guidelines. As components of cartilage, this natural form is essential in promoting cartilage growth and the appearance of youthful skin.

"Jarrow Formulas joins the elite class of reputable companies that use BioCell Collagen II in their formulas," said Suhail Ishaq, vice president of BioCell Technology, LLC. "Once again, consumers can feel assured that they are receiving only the highest quality ingredients that they would expect from an industry leader such as Jarrow Formulas."

Jarrow Formulas Skin Optimizer is an advanced skin care formula with BioCell Collagen II and other highly effective supporting nutrients that have been shown clinically to enhance skin integrity.

Jarrow Formulas Hyaluronic Acid Complex provides the fluid matrix for joint lubrication, skin hydration, and skin repair. Unlike ordinary collagen products, patented BioCell Collagen II is a rich source of bioavailable hyaluronic acid and is clinically proven to support joint health. Each capsule provides 50mg of bioavailable hyaluronic acid.

Jarrow Formulas, Inc. is a nutritional supplement formulator and marketer founded in 1977 and incorporated in 1988. Jarrow Formulas, Inc. is active in regulatory affairs, helping to maintain Americans' rights to free access to dietary supplements. For more information, contact Mark Becker, director, advertising/communications, toll-free at (800) 726-0886 or access the Jarrow Formulas Web site at http://www.Jarrow.com.

Founded in 1997, BioCell Technology, LLC owns the exclusive rights to license BioCell Collagen II under the United States Patents #6,025,327, 6,323,319, 6,780,841, other U.S. and foreign patents pending. BioCell Collagen II is a branded dietary ingredient that is available to dietary supplement and functional foods manufacturers to market under their own brand name or formulas. For more information on BioCell Collagen II, contact Suhail Ishaq at BioCell Technology, LLC at (714) 632-1231, or visit http://www.biocelltechnology.com.


'/>"/>
SOURCE BioCell Technology, LLC
Copyright©2007 PR Newswire.
All rights reserved

Related biology technology :

1. Merge launches diagnostic mammography workstation in Europe
2. Einstein Wireless launches cellular alert system
3. Logistics Health launches compliance management tool
4. UW-Madison launches new high-speed research network
5. UWM launches research foundation
6. TeraMedica launches information manager
7. GE Healthcare launches hybrid electronic record
8. Cedara launches new version of DICOM toolkit
9. Merge launches Spanish version of imaging tool
10. Doyle launches 2025 alternative energy plan
11. Jellyfish launches comparative shopping website
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/24/2017)... , Feb. 24, 2017  OncoSec Medical Incorporated ("OncoSec") ... will host a Key Opinion Leader event to highlight ... oral and poster presentation at the upcoming 2017 ASCO-SITC ... KOL event will be held in-person and via live ... / 9:00 AM PST at the Lotte New York ...
(Date:2/23/2017)... 23, 2017  MIODx announced today that it ... immunotherapy technologies from the University of California, San ... to monitor a patient for response to immune ... The second license extends the technology with a ... to have an immune-related adverse event (IRAE) from ...
(Date:2/23/2017)... ... February 23, 2017 , ... ... that in a published evaluation of multiple immunoassay-based threat detection technologies by ... Energy Laboratory, PathSensors’ CANARY® biosensor threat detection technology was found to have ...
(Date:2/23/2017)... DIEGO , Feb. 23, 2017 ... research tools, announced the acquisition of GenWay Biotech ... a comprehensive service and product offering for both ... acquisition will facilitate growth and enhance capabilities for ... antibodies, and ELISA assays will nicely complement ASB,s ...
Breaking Biology Technology:
(Date:1/26/2017)... -- Acuity Market Intelligence today released the 2017 "Ten ... characterizes 2017 as a "breakout" year for biometrics ... new understanding of the potential benefits these technologies ... are often perceived as threats to privacy and ... Acuity Market intelligence. "However, taken together these technologies ...
(Date:1/24/2017)... YORK , Jan. 24, 2017 ... study of the laboratory use of nuclear magnetic ... 363 experienced end-users and profiled current practices, developments, ... years, as well as growth and opportunities. These ... Instrument suppliers, NMR instruments, needs and innovation requirements, ...
(Date:1/23/2017)... latest mobile market research from Acuity Market Intelligence reveals ... average price of a biometric smartphone decreased from $849 ... are now 120 sub-$150 models on the market at ... a year ago at an average price of $127. ... Acuity Market Intelligence Principal, "Biometric Smartphones are a global ...
Breaking Biology News(10 mins):